DQAsomes: A Novel Potential Drug and Gene Delivery System Made from Dequalinium™

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Pharmaceutical Research

• Publication date

  1998-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1023/A:1011991307631PMID 9523323
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dequalinium, a selective blocker of the slow afterhyperpolarization in rat sympathetic neurones in culture.

  1994cited by this paper
• Effect of dequalinium on K1735-M2 melanoma cell growth, directional migration and invasion in vitro.

  1992cited by this paper
• Digitonin permeabilization does not affect mitochondrial function and allows the determination of the mitochondrial membrane potential of Trypanosoma cruzi in situ.

  1991cited by this paper
• Enhanced in vitro uptake and retention of 3H-tetraphenylphosphonium by nervous system tumor cells.

  1991cited by this paper
• Inhibition of rodent protein kinase C by the anticarcinoma agent dequalinium.

  1990cited by this paper
• Study of the selective cytotoxic properties of cationic, lipophilic mitochondrial-specific compounds in gynecologic malignancies.

  1990cited by this paper
• Inhibition and photoinactivation of the bovine heart mitochondrial F1-ATPase by the cytotoxic agent, dequalinium.

  1988cited by this paper
• Dequalinium, a topical antimicrobial agent, displays anticarcinoma activity based on selective mitochondrial accumulation.

  1987cited by this paper
• Selective antimitochondrial agents inhibit calmodulin.

  1986cited by this paper
• Micellar properties and surface activity of some bolaform drugs in aqueous solution

  1980cited by this paper
• SALTS OF DECAMETHYLENE‐BIS‐4‐AMINOQUINALDINIUM (“DEQUADIN”) * , A NEW ANTIMICROBIAL AGENT

  1956cited by this paper

• Advances in lipid-based nanosystems for mitochondrial metabolism modulation: strategies, mechanisms, and applications

  2026cites this paper
• Refining in vitro cytotoxicity of α-mangostin against triple-negative breast cancer using dequalinium-modified liposomal nanocarrier.

  2026cites this paper
• The development of mitochondria-targeted quercetin for rescuing Sertoli cells from oxidative stress

  2025cites this paper
• Tools and delivery technologies for mitochondrial gene editing

  2025cites this paper
• Subcellular two-pronged targeting therapeutics: disrupting mitochondria-endoplasmic reticulum communication in inflammatory disorders.

  2025cites this paper
• Engineered mitochondria in diseases: mechanisms, strategies, and applications

  2025cites this paper
• Modification in Structures of Active Compounds in Anticancer Mitochondria-Targeted Therapy

  2025cites this paper
• Recent Advances in Nucleic Acid-Based Probes for Organelle-Specific Imaging

  2025cites this paper
• Nanotechnological Approaches for Mitochondrial Targeting in Neurodegenerative Diseases.

  2025cites this paper
• Mitochondria-Targeted Nanoparticles and their Progress in the Treatment of Cerebral Ischaemia-Reperfusion Injury

  2025cites this paper
• Unlocking the mitochondria for nanomedicine-based Treatments: Overcoming biological Barriers, improving Designs, and selecting verification techniques.

  2024cites this paper
• An Insight into the Approach Taken to Appurtenances Disorders Linked to Mitochondria

  2024cites this paper
• Mitochondrial-targeted liposome-based drug delivery – therapeutic potential and challenges

  2024cites this paper
• DQAsomes as a Coenzyme Q10 Delivery Vehicle: A Step Forward Therapy in Leigh Disease

  2024cites this paper
• Mitochondria-targeted nanotherapeutics: A new Frontier in neurodegenerative disease treatment.

  2024cites this paper
• A Sojourn on Mitochondria Targeted Drug Delivery Systems for cancer: Strategies, Clinical and Future Prospects.

  2023cites this paper
• Curcumin and N-Acetylcysteine Nanocarriers Alone or Combined with Deferoxamine Target the Mitochondria and Protect against Neurotoxicity and Oxidative Stress in a Co-Culture Model of Parkinson’s Disease

  2023influential citation
• A New Reverse Phase High-Performance Liquid Chromatography (RP-HPLC) Method for Determination of Kinetin Riboside (Plant Hormone) in Dequalinium Chloride Based Self-assembled Vesicles: Development, Validation, and Force Degradation Study

  2023cites this paper
• Functionalized and Nonfunctionalized Nanosystems for Mitochondrial Drug Delivery with Metallic Nanoparticles

  2023cites this paper
• Nanomedicine in cancer therapy

  2023cites this paper
• Reduction-Responsive Cationic Vesicles from Bolaamphiphiles with Ionizable Amino Acid or Dipeptide Polar Heads

  2023cites this paper
• Engineering metabolism to modulate immunity.

  2023cites this paper
• Recent Updates on the Efficacy of Mitocans in Photo/Radio-Therapy for Targeting Metabolism in Chemo/Radio-Resistant Cancers: Nanotherapeutics.

  2023cites this paper
• Mitochondria-Targeted, Nanoparticle-Based Drug-Delivery Systems: Therapeutics for Mitochondrial Disorders

  2022cites this paper
• Rational Designs at the Forefront of Mitochondria-Targeted Gene Delivery: Recent Progress and Future Perspectives.

  2022cites this paper
• Subcellular delivery of lipid nanoparticles to endoplasmic reticulum and mitochondria.

  2022cites this paper
• Organelle-targeted therapies: a comprehensive review on system design for enabling precision oncology

  2022cites this paper
• Nanomaterials Respond to Lysosomal Function for Tumor Treatment

  2022cites this paper
• Mitochondrial targeting of potent nanoparticulated drugs in combating diseases

  2022cites this paper
• Biomedically Relevant Applications of Bolaamphiphiles and Bolaamphiphile-Containing Materials

  2021cites this paper
• Mitochondria‐targeted nanoparticles in treatment of neurodegenerative diseases

  2021cites this paper
• Organelle-level precision with next-generation targeting technologies

  2021cites this paper
• Soft materials as biological and artificial membranes.

  2021cites this paper
• Organelle targeting: Focus on the mitochondria

  2021cites this paper
• Nanotechnology, mitochondria, and cancer

  2021cites this paper
• Recent developments in mitochondrial medicine (Part 1)

  2021cites this paper
• Mitochondrial nanomedicine: Subcellular organelle-specific delivery of molecular medicines.

  2021cites this paper
• Novel Strategies for Disrupting Cancer-Cell Functions with Mitochondria-Targeted Antitumor Drug–Loaded Nanoformulations

  2021cites this paper
• DQAsomes as the Prototype of Mitochondria-Targeted Pharmaceutical Nanocarriers : An Update.

  2021cites this paper
• Engineering Genetic Systems for Treating Mitochondrial Diseases

  2021cites this paper
• Micellar Nanocarriers of Hydroxytyrosol Are Protective against Parkinson’s Related Oxidative Stress in an In Vitro hCMEC/D3-SH-SY5Y Co-Culture System

  2021cites this paper
• Using FDA-approved drugs as off-label fluorescent dyes for optical biopsies: from in silico design to ex vivo proof-of-concept

  2021cites this paper
• Novel strategies of third level (Organelle-specific) drug targeting: An innovative approach of modern therapeutics

  2021cites this paper
• Recent Advances in Chemical Biology of Mitochondria Targeting

  2021cites this paper
• Lipid nanovesicles for biomedical applications: 'What is in a name'?

  2021cites this paper
• Medicinal applications and molecular targets of dequalinium chloride.

  2021cites this paper
• Anti-virulence strategies for Clostridioides difficile infection: advances and roadblocks

  2020cites this paper
• Intelligentes Design von Nanomaterialien für Mitochondrien‐gerichtete Nanotherapeutika

  2020cites this paper
• Power of mitochondrial drug delivery systems to produce innovative nanomedicines.

  2020cites this paper
• Mitochondria-targeted drug delivery in neurodegenerative diseases

  2020cites this paper
• Lipid‐based gene delivery to macrophage mitochondria for atherosclerosis therapy

  2020cites this paper
• Smart Design of Nanomaterials for Mitochondria-Targeted Nanotherapeutics.

  2020cites this paper
• Antisense Antibacterial Compounds.

  2020cites this paper
• N-Acetylcysteine Nanocarriers Protect against Oxidative Stress in a Cellular Model of Parkinson’s Disease

  2020cites this paper
• Management of Glioblastoma Multiforme by Phytochemicals: Applications of Nanoparticle Based Targeted Drug Delivery System.

  2020cites this paper
• Multifunctional nanoplatforms for subcellular delivery of drugs in cancer therapy

  2020cites this paper
• Pharmacophore hybridisation and nanoscale assembly to discover self-delivering lysosomotropic new-chemical entities for cancer therapy

  2020cites this paper
• Single Small Molecule‐Assembled Mitochondria Targeting Nanofibers for Enhanced Photodynamic Cancer Therapy In Vivo

  2020cites this paper
• Synthesis and Determination of Critical Micelle Concentration of Betainthioates Surfactants

  2020cites this paper
• Novel Mitochondria-targeted Drugs for Cancer Therapy.

  2020cites this paper
• Mitocans Revisited: Mitochondrial Targeting as Efficient Anti-Cancer Therapy

  2020cites this paper
• Polyplexes by Polymerized Dequalinium and Bifunctional Aptamer for Mitochondrial Targeting Drug Release to Overcome Drug Resistance.

  2020cites this paper
• Mapping and editing animal mitochondrial genomes: can we overcome the challenges?

  2019cites this paper
• Oligonucleotide loaded polypeptide‐peptide nanoparticles towards mitochondrial‐targeted delivery

  2019cites this paper
• Aiming for the target: Mitochondrial drug delivery in traumatic brain injury

  2019cites this paper
• Recent progress on mitochondrial targeted cancer therapy based on inorganic nanomaterials

  2019cites this paper
• A photo-regulated aptamer sensor for spatiotemporally controlled monitoring of ATP in the mitochondria of living cells†

  2019cites this paper
• Interaction of dequalinium chloride with phosphatidylcholine bilayers: A biophysical study with consequences on the development of lipid-based mitochondrial nanomedicines.

  2019cites this paper
• Deferoxamine and Curcumin Loaded Nanocarriers Protect Against Rotenone-Induced Neurotoxicity

  2019influential citation
• Small-Molecule Modulators of Mitochondrial Channels as Chemotherapeutic Agents.

  2019cites this paper
• Antitumor Effect of Lonidamine-Polypeptide-Peptide Nanoparticles in Breast Cancer Models.

  2019cites this paper
• Import of Proteins and Nucleic Acids into Mitochondria

  2018cites this paper
• Targeting Therapeutic Nucleic Acids into Mitochondria: A Long Challenge

  2018cites this paper
• Aggregation behaviour of triphenylphosphonium bolaamphiphiles.

  2018cites this paper
• Organ-based drug delivery

  2018cites this paper
• Bifunctional peptide hybrids targeting the matrix of mitochondria

  2018cites this paper
• Mitochondrial-Targeting Anticancer Agent Conjugates and Nanocarrier Systems for Cancer Treatment

  2018cites this paper
• Mitochondria-targeting theranostics

  2018cites this paper
• From organelle over cell to tissue: Development of fluorescence-based methods to monitor the fate of model transporting structures

  2018cites this paper
• Mitochondria-targeting drug conjugates for cytotoxic, anti-oxidizing and sensing purposes: current strategies and future perspectives

  2018cites this paper
• Negatively charged polypeptide-peptide nanoparticles showing efficient drug delivery to the mitochondria.

  2018cites this paper
• A high-throughput screening campaign to identify inhibitors of DXP reductoisomerase (IspC) and MEP cytidylyltransferase (IspD).

  2018cites this paper
• Dequalinium‐based functional nanosomes show increased mitochondria targeting and anticancer effect

  2018cites this paper
• Cationic Amphiphilic Bolaamphiphile-based Delivery of Antisense Oligonucleotides Provides a Potentially Microbiome Sparing Treatment for C. difficile

  2018cites this paper
• Cell-Penetrating Peptides for Mitochondrial Targeting

  2018cites this paper
• Photosensitizer-mediated mitochondria-targeting nanosized drug carriers: Subcellular targeting, therapeutic, and imaging potentials.

  2017cites this paper
• Cationic liposomal vectors incorporating a bolaamphiphile for oligonucleotide antimicrobials.

  2017cites this paper
• Nanopreparations for mitochondria targeting drug delivery system: Current strategies and future prospective

  2017cites this paper
• Inclusion of oligonucleotide antimicrobials in biocompatible cationic liposomes: A structural study.

  2017cites this paper
• Reinforcing mitochondrial functions in aging brain: An insight into Parkinson's disease therapeutics.

  2017cites this paper
• Nanoparticle design considerations for molecular imaging of apoptosis: Diagnostic, prognostic, and therapeutic value☆,☆☆

  2017cites this paper
• Heat shock proteins and cancer: How can nanomedicine be harnessed?

  2017cites this paper
• Functional nanosome for enhanced mitochondria-targeted gene delivery and expression.

  2017cites this paper
• Mitochondrial transit peptide exhibits cell penetration ability and efficiently delivers macromolecules to mitochondria

  2016cites this paper
• Interaction between a cationic bolaamphiphile and DNA: The route towards nanovectors for oligonucleotide antimicrobials.

  2016cites this paper
• Nanotechnology inspired tools for mitochondrial dysfunction related diseases.

  2016cites this paper
• Intracellular delivery of nanocarriers and targeting to subcellular organelles

  2016cites this paper
• The Eighth Central European Conference “Chemistry towards Biology”: Snapshot

  2016cites this paper
• Phospholipid- and Nonphospholipid-Based Vesicles for Drug and DNA Delivery to Mitochondria in Living Mammalian Cells

  2016cites this paper
• Overview of Present Problems Facing Commercialization of Nanomedicines

  2016cites this paper